A Study of Extended Total Mesopancreas Excision(eTME) for Pancreatic Head Adenocarcinoma.
NCT04147403 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2019-11-01
Summary
The study of extended total mesopancreas excision(eTME) for pancreatic head adenocarcinoma is a retrospective multicenter cohort, collecting medical records and follow-up data of patients who underwent radical resection with pancreatic head adenocarcinoma.
Conditions
- Pancreas Adenocarcinoma
Sponsors & Collaborators
-
Ruijin Hospital
collaborator OTHER -
Shanghai Zhongshan Hospital
collaborator OTHER -
Shanghai Jiao Tong University School of Medicine
lead OTHER
Principal Investigators
-
Yingbin Liu, Ph.D. · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-01
- Primary Completion
- 2018-10-31
- Completion
- 2020-10-31
Countries
- China
Study Locations
More Related Trials
-
Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery
NCT06164769 ·Status: RECRUITING ·Phase: NA
-
Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma
NCT02928081 ·Status: UNKNOWN ·Phase: NA
-
Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC
NCT04855331 ·Status: RECRUITING ·Phase: NA
-
Impact of Three-dimensional Visualization on Operation Strategy and Complications for Pancreatic Cancer
NCT03749005 ·Status: UNKNOWN
-
Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes
NCT07272109 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.
NCT04115527 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Translational Research on Locally Advanced Pancreatic Adenocarcinoma
NCT03009253 ·Status: UNKNOWN ·Phase: NA
-
Construction and Evaluation of China's Advanced Pancreatic Tumor Big Data Center
NCT05141656 ·Status: UNKNOWN
-
The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer
NCT06873178 ·Status: ACTIVE_NOT_RECRUITING
-
Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.
NCT05723978 ·Status: COMPLETED
-
Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers
NCT06703905 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis
NCT06307080 ·Status: RECRUITING ·Phase: NA
-
Impact of Pancreatic Endoscopic Drainage on Exocrine Pancreatic Function in Unresectable Pancreatic Cancer
NCT05244174 ·Status: UNKNOWN ·Phase: NA
-
Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm
NCT05907824 ·Status: UNKNOWN
-
Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study
NCT01455610 ·Status: UNKNOWN
-
Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
NCT02005419 ·Status: COMPLETED ·Phase: PHASE2
-
Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery
NCT05830019 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer
NCT01419002 ·Status: TERMINATED ·Phase: PHASE3
-
Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma
NCT05869474 ·Status: RECRUITING ·Phase: NA
-
HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma
NCT02850874 ·Status: WITHDRAWN ·Phase: PHASE2
-
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
NCT02981719 ·Status: COMPLETED ·Phase: NA
-
The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients
NCT03770559 ·Status: UNKNOWN ·Phase: NA
-
A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC
NCT04726956 ·Status: COMPLETED
-
A Study of Pancreatic Cancer in Xenografts From Liver Metastases
NCT01774643 ·Status: COMPLETED
-
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
NCT04211948 ·Status: UNKNOWN ·Phase: NA